checkAd

     142  0 Kommentare Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting - Seite 3

    Contacts:

    For Investors:
    Natalie Wildenradt
    investors@bdtherapeutics.com

    Lesen Sie auch

    For Media:
    Kathy Vincent
    (310) 403-8951
    media@bdtherapeutics.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting - Seite 3 BDTX-1535 nominated as development candidate with IND-enabling studies underwayPre-clinical data support novel and differentiated approach in GBM CAMBRIDGE, Mass. and NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -  Black Diamond Therapeutics, …